{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:57:04Z","timestamp":1765486624969,"version":"3.40.3"},"publisher-location":"Cham","reference-count":112,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030590376"},{"type":"electronic","value":"9783030590383"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-59038-3_8","type":"book-chapter","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T15:06:56Z","timestamp":1624979216000},"page":"137-150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pineal Gland Tumor Microenvironment"],"prefix":"10.1007","author":[{"given":"Joham","family":"Choque-Velasquez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szymon","family":"Baluszek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Colasanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajjad","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juha","family":"Hernesniemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,30]]},"reference":[{"key":"8_CR1","doi-asserted-by":"crossref","unstructured":"Choque-Velasquez J, Resendiz-Nieves J, Jahromi BR, et al (2019) Extent of resection and long-term survival of pineal region tumors in Helsinki neurosurgery. World Neurosurg. Published online 29 July 2019","DOI":"10.1016\/j.wneu.2019.07.169"},{"issue":"2\u20133","key":"8_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.neuchi.2014.02.006","volume":"61","author":"C Mottolese","year":"2015","unstructured":"Mottolese C, Beuriat PA, Szathmari A (2015) Pineal tumours: experience of the French National Register and the Lyon School, results and considerations. Neuro-Chirurgie 61(2\u20133):223\u2013235. https:\/\/doi.org\/10.1016\/j.neuchi.2014.02.006","journal-title":"Neuro-Chirurgie"},{"key":"8_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000210049","volume":"23","author":"S Shibui","year":"2009","unstructured":"Shibui S, Nomura K (2009) Statistical analysis of pineal tumors based on the data of Brain Tumor Registry of Japan. Prog Neurol Surg 23:1\u201311. https:\/\/doi.org\/10.1159\/000210049","journal-title":"Prog Neurol Surg"},{"issue":"3","key":"8_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11060-009-9881-9","volume":"94","author":"M Al-Hussaini","year":"2009","unstructured":"Al-Hussaini M, Sultan I, Abuirmileh N, Jaradat I, Qaddoumi I (2009) Pineal gland tumors: experience from the SEER database. J Neuro-Oncol 94(3):351\u2013358. https:\/\/doi.org\/10.1007\/s11060-009-9881-9","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"8_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.31486\/toj.18.0110","volume":"19","author":"C Carr","year":"2019","unstructured":"Carr C, O\u2019Neill BE, Hochhalter CB, Strong MJ, Ware ML (2019) Biomarkers of Pineal Region tumors: a review. Ochsner J 19(1):26\u201331. https:\/\/doi.org\/10.31486\/toj.18.0110","journal-title":"Ochsner J"},{"key":"8_CR6","unstructured":"Nakazato Y, Jouvet A, Scheithauer BW (2006) Pineocytoma. In: WHO classification of tumors of the central nervous system, 4th edn. World Health Organization, pp 121\u2013122"},{"key":"8_CR7","unstructured":"Nakazato Y, Jouvet A, Scheithauer BW (2006) Pineoblastoma. In: WHO classification of tumours of the central nervous system, 4th edn. World Health Organization, pp 126\u2013127"},{"key":"8_CR8","unstructured":"Nakazato Y, Jouvet A, Scheithauer BW (2006). Pineal parenchymal tumours of intermediate differentiation. In: WHO classification of tumours of the central nervous system, 4th edn. World Health Organization, pp 124\u2013125"},{"issue":"5","key":"8_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3174\/ajnr.A2583","volume":"33","author":"AG Osborn","year":"2012","unstructured":"Osborn AG, Salzman KL, Thurnher MM, Rees JH, Castillo M (2012) The new World Health Organization classification of central nervous system tumors: what can the neuroradiologist really say? AJNR Am J Neuroradiol 33(5):795\u2013802. https:\/\/doi.org\/10.3174\/ajnr.A2583","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"8_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"key":"8_CR11","unstructured":"Choque-Velasquez J, Resendiz-Nieves JC, Jahromi BR, et al (2018) Pineal parenchymal tumors of intermediate differentiation: a long-term follow-up study in Helsinki neurosurgery. World neurosurg. Published online 1 Nov 2018"},{"issue":"3","key":"8_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/PAI.0000000000000565","volume":"27","author":"D Chatterjee","year":"2019","unstructured":"Chatterjee D, Lath K, Singla N, Kumar N, Radotra BD (2019) Pathologic prognostic factors of pineal parenchymal tumor of intermediate differentiation. Appl Immunohistochem Mol Morphol 27(3):210\u2013215. https:\/\/doi.org\/10.1097\/PAI.0000000000000565","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"2","key":"8_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.4103\/0028-3886.258045","volume":"67","author":"A Verma","year":"2019","unstructured":"Verma A, Epari S, Bakiratharajan D et al (2019) Primary pineal tumors - unraveling histological challenges and certain clinical myths. Neurol India 67(2):491\u2013502. https:\/\/doi.org\/10.4103\/0028-3886.258045","journal-title":"Neurol India"},{"key":"8_CR14","doi-asserted-by":"publisher","first-page":"100477","DOI":"10.1016\/j.inat.2019.100477","volume":"18","author":"J Choque-Velasquez","year":"2019","unstructured":"Choque-Velasquez J, Resendiz-Nieves JC, Jahromi BR et al (2019) Pineoblastomas: a long-term follow up study of three cases in Helsinki neurosurgery. Interdiscip Neurosurg 18:100477. https:\/\/doi.org\/10.1016\/j.inat.2019.100477","journal-title":"Interdiscip Neurosurg"},{"key":"8_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000210050","volume":"23","author":"K Sato","year":"2009","unstructured":"Sato K, Kubota T (2009) Pathology of pineal parenchymal tumors. Prog Neurol Surg 23:12\u201325. https:\/\/doi.org\/10.1159\/000210050","journal-title":"Prog Neurol Surg"},{"issue":"1","key":"8_CR16","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1038\/s41467-018-05029-3","volume":"9","author":"M Snuderl","year":"2018","unstructured":"Snuderl M, Kannan K, Pfaff E et al (2018) Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma. Nat Commun 9(1):2868. https:\/\/doi.org\/10.1038\/s41467-018-05029-3","journal-title":"Nat Commun"},{"issue":"4","key":"8_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00401-014-1318-7","volume":"128","author":"L de Kock","year":"2014","unstructured":"de Kock L, Sabbaghian N, Druker H et al (2014) Germ-line and somatic DICER1 mutations in pineoblastoma. Acta Neuropathol 128(4):583\u2013595. https:\/\/doi.org\/10.1007\/s00401-014-1318-7","journal-title":"Acta Neuropathol"},{"issue":"5","key":"8_CR18","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00401-019-01990-5","volume":"137","author":"JC Lee","year":"2019","unstructured":"Lee JC, Mazor T, Lao R et al (2019) Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma. Acta Neuropathol 137(5):851\u2013854. https:\/\/doi.org\/10.1007\/s00401-019-01990-5","journal-title":"Acta Neuropathol"},{"issue":"1","key":"8_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.25149\/case-reports.v8i1.162","volume":"8","author":"J Choque-Velasquez","year":"2019","unstructured":"Choque-Velasquez J, Resendiz-Nieves JC, Jahromi BR et al (2019) Pineocytomas: a long-term follow up study of four cases in Helsinki neurosurgery. J Case Rep Med 8(1):5\u20135","journal-title":"J Case Rep Med"},{"issue":"1","key":"8_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/neuros\/nyx005","volume":"81","author":"KA Parikh","year":"2017","unstructured":"Parikh KA, Venable GT, Orr BA et al (2017) Pineoblastoma-the experience at St. Jude Children\u2019s Research Hospital. Neurosurgery 81(1):120\u2013128. https:\/\/doi.org\/10.1093\/neuros\/nyx005","journal-title":"Neurosurgery"},{"issue":"7","key":"8_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/jmedgenet-2012-100898","volume":"49","author":"N Sabbaghian","year":"2012","unstructured":"Sabbaghian N, Hamel N, Srivastava A, Albrecht S, Priest JR, Foulkes WD (2012) Germline DICER1 mutation and associated loss of heterozygosity in a pineoblastoma. J Med Genet 49(7):417\u2013419. https:\/\/doi.org\/10.1136\/jmedgenet-2012-100898","journal-title":"J Med Genet"},{"issue":"23","key":"8_CR22","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1101\/gad.1848209","volume":"23","author":"MS Kumar","year":"2009","unstructured":"Kumar MS, Pester RE, Chen CY et al (2009) Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev 23(23):2700\u20132704. https:\/\/doi.org\/10.1101\/gad.1848209","journal-title":"Genes Dev"},{"key":"8_CR23","doi-asserted-by":"publisher","unstructured":"Martinez H, Nagurney M, Wang Z, et al (2019) ATRX mutations in pineal parenchymal Tumors of intermediate differentiation. J Neuropathol Exp Neurol. Published online 27 May 2019. https:\/\/doi.org\/10.1093\/jnen\/nlz050","DOI":"10.1093\/jnen\/nlz050"},{"issue":"2","key":"8_CR24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11060-019-03173-4","volume":"143","author":"H Gittleman","year":"2019","unstructured":"Gittleman H, Cioffi G, Vecchione-Koval T et al (2019) Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015. J Neuro-Oncol 143(2):251\u2013260. https:\/\/doi.org\/10.1007\/s11060-019-03173-4","journal-title":"J Neuro-Oncol"},{"key":"8_CR25","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2016) WHO classification of tumours of the central nervous system, revised 4th edn. World Health Organization"},{"issue":"2","key":"8_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3171\/jns.1985.63.2.0155","volume":"63","author":"MT Jennings","year":"1985","unstructured":"Jennings MT, Gelman R, Hochberg F (1985) Intracranial germ-cell tumors: natural history and pathogenesis. J Neurosurg 63(2):155\u2013167. https:\/\/doi.org\/10.3171\/jns.1985.63.2.0155","journal-title":"J Neurosurg"},{"issue":"3","key":"8_CR27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00401-017-1673-2","volume":"133","author":"S Fukushima","year":"2017","unstructured":"Fukushima S, Yamashita S, Kobayashi H et al (2017) Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas. Acta Neuropathol 133(3):445\u2013462. https:\/\/doi.org\/10.1007\/s00401-017-1673-2","journal-title":"Acta Neuropathol"},{"key":"8_CR28","doi-asserted-by":"publisher","unstructured":"Sato K, Takeuchi H, Kubota T (2009) Pathology of intracranial germ cell tumors. In: Pineal Region tumors. KARGER, pp 59\u201375. https:\/\/doi.org\/10.1159\/000210053","DOI":"10.1159\/000210053"},{"issue":"9","key":"8_CR29","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/annonc\/mdh301","volume":"15","author":"HJ Schmoll","year":"2004","unstructured":"Schmoll HJ, Souchon R, Krege S et al (2004) European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15(9):1377\u20131399. https:\/\/doi.org\/10.1093\/annonc\/mdh301","journal-title":"Ann Oncol"},{"issue":"2","key":"8_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11060-009-9951-z","volume":"96","author":"AP Kyritsis","year":"2010","unstructured":"Kyritsis AP (2010) Management of primary intracranial germ cell tumors. J Neuro-Oncol 96(2):143\u2013149. https:\/\/doi.org\/10.1007\/s11060-009-9951-z","journal-title":"J Neuro-Oncol"},{"issue":"9","key":"8_CR31","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/annonc\/mdh301","volume":"15","author":"HJ Schmoll","year":"2004","unstructured":"Schmoll HJ, Souchon R, Krege S et al (2004) European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15(9):1377\u20131399. https:\/\/doi.org\/10.1093\/annonc\/mdh301","journal-title":"Ann Oncol"},{"issue":"6","key":"8_CR32","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s12094-015-1423-7","volume":"18","author":"R Gonzalez-Exposito","year":"2016","unstructured":"Gonzalez-Exposito R, Merino M, Aguayo C (2016) Molecular biology of testicular germ cell tumors. Clin Transl Oncol 18(6):550\u2013556. https:\/\/doi.org\/10.1007\/s12094-015-1423-7","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"8_CR33","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0002-9440(10)64631-7","volume":"157","author":"H Roelofs","year":"2000","unstructured":"Roelofs H, Mostert MC, Pompe K et al (2000) Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis. Am J Pathol 157(4):1155\u20131166. https:\/\/doi.org\/10.1016\/S0002-9440(10)64631-7","journal-title":"Am J Pathol"},{"issue":"4","key":"8_CR34","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41416-019-0381-1","volume":"120","author":"LCJ Dorssers","year":"2019","unstructured":"Dorssers LCJ, Gillis AJM, Stoop H et al (2019) Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development. Br J Cancer 120(4):444\u2013452. https:\/\/doi.org\/10.1038\/s41416-019-0381-1","journal-title":"Br J Cancer"},{"issue":"6","key":"8_CR35","doi-asserted-by":"publisher","first-page":"529","DOI":"10.4161\/cbt.10.6.13227","volume":"10","author":"A D\u00edez-Torre","year":"2010","unstructured":"D\u00edez-Torre A, Silv\u00e1n U, D\u00edaz-N\u00fa\u00f1ez M, Arechaga J (2010) The role of microenvironment in testicular germ cell tumors. Cancer Biol Ther 10(6):529\u2013536. https:\/\/doi.org\/10.4161\/cbt.10.6.13227","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"8_CR36","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.4049\/jimmunol.0803424","volume":"182","author":"SN Willis","year":"2009","unstructured":"Willis SN, Mallozzi SS, Rodig SJ et al (2009) The microenvironment of germ cell tumors Harbors a prominent antigen-driven humoral response. J Immunol 182(5):3310\u20133317. https:\/\/doi.org\/10.4049\/jimmunol.0803424","journal-title":"J Immunol"},{"key":"8_CR37","doi-asserted-by":"publisher","unstructured":"Takami H, Fukushima S, Aoki K, et al (2019) Intratumoural immune cell landscape in germinoma reveals multipotent lineages and exhibits prognostic significance. Neuropathol Appl Neurobiol. Published online 29 July 2019:nan.12570. https:\/\/doi.org\/10.1111\/nan.12570","DOI":"10.1111\/nan.12570"},{"issue":"4","key":"8_CR38","doi-asserted-by":"publisher","first-page":"e1305535","DOI":"10.1080\/2162402X.2017.1305535","volume":"6","author":"PJ Siska","year":"2017","unstructured":"Siska PJ, Johnpulle RAN, Zhou A et al (2017) Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling. OncoImmunology 6(4):e1305535. https:\/\/doi.org\/10.1080\/2162402X.2017.1305535","journal-title":"OncoImmunology"},{"issue":"11","key":"8_CR39","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1158\/2326-6066.CIR-16-0087","volume":"4","author":"S Shah","year":"2016","unstructured":"Shah S, Ward JE, Bao R, Hall CR, Brockstein BE, Luke JJ (2016) Clinical response of a patient to anti-PD-1 immunotherapy and the immune landscape of testicular germ cell tumors. Cancer Immunol Res 4(11):903\u2013909. https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0087","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"8_CR40","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/annonc\/mdv574","volume":"27","author":"Z Cierna","year":"2016","unstructured":"Cierna Z, Mego M, Miskovska V et al (2016) Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors. Ann Oncol 27(2):300\u2013305. https:\/\/doi.org\/10.1093\/annonc\/mdv574","journal-title":"Ann Oncol"},{"issue":"4","key":"8_CR41","doi-asserted-by":"publisher","first-page":"e0194594","DOI":"10.1371\/journal.pone.0194594","volume":"13","author":"B Liu","year":"2018","unstructured":"Liu B, Arakawa Y, Yokogawa R et al (2018) PD-1\/PD-L1 expression in a series of intracranial germinoma and its association with Foxp3+ and CD8+ infiltrating lymphocytes. PLOS ONE 13(4):e0194594. https:\/\/doi.org\/10.1371\/journal.pone.0194594","journal-title":"PLOS ONE"},{"issue":"1","key":"8_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/annonc\/mdx680","volume":"29","author":"N Adra","year":"2018","unstructured":"Adra N, Einhorn LH, Althouse SK et al (2018) Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206. Ann Oncol 29(1):209\u2013214. https:\/\/doi.org\/10.1093\/annonc\/mdx680","journal-title":"Ann Oncol"},{"key":"8_CR43","doi-asserted-by":"publisher","unstructured":"Chovanec M, Mardiak J, Mego M (2019) Immune mechanisms and possible immune therapy in testicular germ cell tumours. Andrology. Published online 6 June 2019:andr.12656. https:\/\/doi.org\/10.1111\/andr.12656","DOI":"10.1111\/andr.12656"},{"issue":"3","key":"8_CR44","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1365-2613.2000.00151.x","volume":"81","author":"B Bols","year":"2001","unstructured":"Bols B, Jensen L, Jensen A, Braendstrup O (2001) Immunopathology of in situ seminoma. Int J Exp Pathol 81(3):211\u2013217. https:\/\/doi.org\/10.1046\/j.1365-2613.2000.00151.x","journal-title":"Int J Exp Pathol"},{"issue":"6","key":"8_CR45","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/bjc.2017.467","volume":"118","author":"CD Fankhauser","year":"2018","unstructured":"Fankhauser CD, Sander S, Roth L et al (2018) Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy. Br J Cancer 118(6):825\u2013830. https:\/\/doi.org\/10.1038\/bjc.2017.467","journal-title":"Br J Cancer"},{"key":"8_CR46","doi-asserted-by":"publisher","unstructured":"Svetlovska D, Miskovska V, Cholujova D, et al (2017) Plasma cytokines correlated with disease characteristics, progression-free survival, and overall survival in testicular germ-cell tumor patients. Clin Genitourin Cancer 15(3):411\u2013416.e2. https:\/\/doi.org\/10.1016\/j.clgc.2017.01.027","DOI":"10.1016\/j.clgc.2017.01.027"},{"issue":"5","key":"8_CR47","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1095\/biolreprod.110.087452","volume":"84","author":"P Mital","year":"2011","unstructured":"Mital P, Hinton BT, Dufour JM (2011) The blood-testis and blood-epididymis barriers are more than just their tight junctions1. Biol Reprod 84(5):851\u2013858. https:\/\/doi.org\/10.1095\/biolreprod.110.087452","journal-title":"Biol Reprod"},{"issue":"6","key":"8_CR48","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1750-3639.2011.00491.x","volume":"21","author":"V Rigau","year":"2011","unstructured":"Rigau V, Zouaoui S, Mathieu-Daud\u00e9 H et al (2011) French brain tumor database: 5-year histological results on 25 756 cases. Brain Pathol 21(6):633\u2013644. https:\/\/doi.org\/10.1111\/j.1750-3639.2011.00491.x","journal-title":"Brain Pathol"},{"issue":"2\u20133","key":"8_CR49","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuchi.2014.01.005","volume":"61","author":"C Mottolese","year":"2015","unstructured":"Mottolese C, Szathmari A, Beuriat PA (2015) Incidence of pineal tumours. A review of the literature. Neurochirurgie 61(2\u20133):65\u201369. https:\/\/doi.org\/10.1016\/j.neuchi.2014.01.005","journal-title":"Neurochirurgie"},{"issue":"4","key":"8_CR50","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3171\/jns.1973.39.4.0455","volume":"39","author":"U DeGirolami","year":"1973","unstructured":"DeGirolami U, Schmidek H (1973) Clinicopathological study of 53 tumors of the pineal region. J Neurosurg 39(4):455\u2013462. https:\/\/doi.org\/10.3171\/jns.1973.39.4.0455","journal-title":"J Neurosurg"},{"key":"8_CR51","doi-asserted-by":"publisher","unstructured":"Shibui S, Nomura K (2009) Statistical analysis of pineal tumors based on the data of brain tumor registry of Japan. In: Progress in neurological surgery, vol. 23. KARGER, pp 1\u201311. https:\/\/doi.org\/10.1159\/000210049","DOI":"10.1159\/000210049"},{"issue":"1","key":"8_CR52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40478-018-0602-5","volume":"6","author":"APY Liu","year":"2018","unstructured":"Liu APY, Harreld JH, Jacola LM et al (2018) Tectal glioma as a distinct diagnostic entity: a comprehensive clinical, imaging, histologic and molecular analysis. Acta Neuropathol Commun 6(1):101. https:\/\/doi.org\/10.1186\/s40478-018-0602-5","journal-title":"Acta Neuropathol Commun"},{"issue":"2\u20134","key":"8_CR53","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/BF01476414","volume":"126","author":"C Lapras","year":"1994","unstructured":"Lapras C, Bognar L, Turjman F et al (1994) Tectal plate gliomas. Part I: microsurgery of the tectal plate gliomas. Acta Neurochir 126(2\u20134):76\u201383. https:\/\/doi.org\/10.1007\/BF01476414","journal-title":"Acta Neurochir"},{"issue":"5","key":"8_CR54","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2217\/cns.15.36","volume":"4","author":"AB Lassman","year":"2015","unstructured":"Lassman AB (2015) Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen? CNS Oncol 4(5):341\u2013346. https:\/\/doi.org\/10.2217\/cns.15.36","journal-title":"CNS Oncol"},{"issue":"15","key":"8_CR55","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1158\/1078-0432.CCR-04-0392","volume":"10","author":"MF Paz","year":"2004","unstructured":"Paz MF, Yaya-Tur R, Rojas-Marcos I et al (2004) CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas. Clin Cancer Res 10(15):4933\u20134938. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0392","journal-title":"Clin Cancer Res"},{"issue":"1","key":"8_CR56","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11060-011-0737-8","volume":"107","author":"WB Pope","year":"2012","unstructured":"Pope WB, Prins RM, Thomas MA et al (2012) Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy. J Neuro-Oncol 107(1):197\u2013205. https:\/\/doi.org\/10.1007\/s11060-011-0737-8","journal-title":"J Neuro-Oncol"},{"issue":"25","key":"8_CR57","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1200\/JCO.2016.71.8726","volume":"35","author":"A Lassaletta","year":"2017","unstructured":"Lassaletta A, Zapotocky M, Mistry M et al (2017) Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas. J Clin Oncol 35(25):2934\u20132941. https:\/\/doi.org\/10.1200\/JCO.2016.71.8726","journal-title":"J Clin Oncol"},{"issue":"7","key":"8_CR58","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/NEN.0000000000000213","volume":"74","author":"AP Becker","year":"2015","unstructured":"Becker AP, Scapulatempo-Neto C, Carloni AC et al (2015) KIAA1549: BRAF gene fusion and FGFR1 hotspot mutations are prognostic factors in Pilocytic Astrocytomas. J Neuropathol Exp Neurol 74(7):743\u2013754. https:\/\/doi.org\/10.1097\/NEN.0000000000000213","journal-title":"J Neuropathol Exp Neurol"},{"key":"8_CR59","unstructured":"Phase II Pediatric study with dabrafenib in combination with Trametinib in patients With HGG and LGG \u2013 Full Text View. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02684058"},{"issue":"1","key":"8_CR60","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nn.4185","volume":"19","author":"D Hambardzumyan","year":"2015","unstructured":"Hambardzumyan D, Gutmann DH, Kettenmann H (2015) The role of microglia and macrophages in glioma maintenance and progression. Nat Neurosci 19(1):20\u201327. https:\/\/doi.org\/10.1038\/nn.4185","journal-title":"Nat Neurosci"},{"issue":"2","key":"8_CR61","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/jemt.1125","volume":"54","author":"B Badie","year":"2001","unstructured":"Badie B, Schartner J (2001) Role of microglia in glioma biology. Microsc Res Tech 54(2):106\u2013113. https:\/\/doi.org\/10.1002\/jemt.1125","journal-title":"Microsc Res Tech"},{"issue":"9","key":"8_CR62","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.celrep.2016.10.052","volume":"17","author":"RL Bowman","year":"2016","unstructured":"Bowman RL, Klemm F, Akkari L et al (2016) Macrophage ontogeny underlies differences in tumor-specific education in brain malignancies. Cell Rep 17(9):2445\u20132459. https:\/\/doi.org\/10.1016\/j.celrep.2016.10.052","journal-title":"Cell Rep"},{"issue":"4","key":"8_CR63","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/febs.14317","volume":"285","author":"C Varol","year":"2018","unstructured":"Varol C, Sagi I (2018) Phagocyte \u2013extracellular matrix crosstalk empowers tumor development and dissemination. FEBS J 285(4):734\u2013751. https:\/\/doi.org\/10.1111\/febs.14317","journal-title":"FEBS J"},{"issue":"12","key":"8_CR64","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1158\/1078-0432.CCR-12-3314","volume":"19","author":"O Bloch","year":"2013","unstructured":"Bloch O, Crane CA, Kaur R, Safaee M, Rutkowski MJ, Parsa AT (2013) Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages. Clin Cancer Res 19(12):3165\u20133175. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-3314","journal-title":"Clin Cancer Res"},{"issue":"50","key":"8_CR65","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1038\/onc.2016.55","volume":"35","author":"A Ellert-Miklaszewska","year":"2016","unstructured":"Ellert-Miklaszewska A, Wisniewski P, Kijewska M et al (2016) Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression. Oncogene 35(50):6366\u20136377. https:\/\/doi.org\/10.1038\/onc.2016.55","journal-title":"Oncogene"},{"issue":"2","key":"8_CR66","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ncb3090","volume":"17","author":"W Zhou","year":"2015","unstructured":"Zhou W, Ke SQ, Huang Z et al (2015) Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nat Cell Biol 17(2):170\u2013182. https:\/\/doi.org\/10.1038\/ncb3090","journal-title":"Nat Cell Biol"},{"issue":"4","key":"8_CR67","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/neuonc\/nov245","volume":"18","author":"N Butowski","year":"2016","unstructured":"Butowski N, Colman H, De Groot JF et al (2016) Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy foundation early phase clinical trials consortium phase II study. Neuro-Oncology 18(4):557\u2013564. https:\/\/doi.org\/10.1093\/neuonc\/nov245","journal-title":"Neuro-Oncology"},{"issue":"10","key":"8_CR68","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/S1470-2045(14)70379-1","volume":"15","author":"R Stupp","year":"2014","unstructured":"Stupp R, Hegi ME, Gorlia T et al (2014) Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 15(10):1100\u20131108. https:\/\/doi.org\/10.1016\/S1470-2045(14)70379-1","journal-title":"Lancet Oncol"},{"issue":"2","key":"8_CR69","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1148\/radiol.2472070898","volume":"247","author":"M Law","year":"2008","unstructured":"Law M, Young RJ, Babb JS et al (2008) Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 247(2):490\u2013498. https:\/\/doi.org\/10.1148\/radiol.2472070898","journal-title":"Radiology"},{"issue":"21","key":"8_CR70","doi-asserted-by":"publisher","first-page":"10529","DOI":"10.18632\/oncotarget.2470","volume":"5","author":"B Langlois","year":"2014","unstructured":"Langlois B, Saupe F, Rupp T et al (2014) AngioMatrix, a signature of the tumor angiogenic switch-specific matrisome, correlates with poor prognosis for glioma and colorectal cancer patients. Oncotarget 5(21):10529\u201310545. https:\/\/doi.org\/10.18632\/oncotarget.2470","journal-title":"Oncotarget"},{"issue":"8","key":"8_CR71","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJMoa1308345","volume":"370","author":"OL Chinot","year":"2014","unstructured":"Chinot OL, Wick W, Mason W et al (2014) Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med 370(8):709\u2013722. https:\/\/doi.org\/10.1056\/NEJMoa1308345","journal-title":"N Engl J Med"},{"issue":"1","key":"8_CR72","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1470-2045(18)30675-2","volume":"20","author":"G Lombardi","year":"2019","unstructured":"Lombardi G, De Salvo GL, Brandes AA et al (2019) Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial. Lancet Oncol 20(1):110\u2013119. https:\/\/doi.org\/10.1016\/S1470-2045(18)30675-2","journal-title":"Lancet Oncol"},{"key":"8_CR73","doi-asserted-by":"publisher","unstructured":"Griveau A, Seano G, Shelton SJ, et al (2018) A glial signature and Wnt7 signaling regulate glioma-vascular interactions and tumor microenvironment. Cancer Cell 33(5):874\u2013889.e7. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.020","DOI":"10.1016\/j.ccell.2018.03.020"},{"key":"8_CR74","doi-asserted-by":"publisher","unstructured":"Sun X, Ma X, Wang J et al (2017) Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21\/VEGF signal. Oncotarget 8(22). https:\/\/doi.org\/10.18632\/oncotarget.16661","DOI":"10.18632\/oncotarget.16661"},{"issue":"12","key":"8_CR75","doi-asserted-by":"publisher","first-page":"14429","DOI":"10.18632\/oncotarget.7418","volume":"7","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Zhang X, Qi L et al (2016) HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K\/Akt\/mTOR signaling pathway in human gliomas. Oncotarget 7(12):14429\u201314440. https:\/\/doi.org\/10.18632\/oncotarget.7418","journal-title":"Oncotarget"},{"key":"8_CR76","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.biomaterials.2018.01.053","volume":"161","author":"X Cui","year":"2018","unstructured":"Cui X, Morales RTT, Qian W et al (2018) Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis. Biomaterials 161:164\u2013178. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.01.053","journal-title":"Biomaterials"},{"issue":"1","key":"8_CR77","doi-asserted-by":"publisher","first-page":"e15846","DOI":"10.1371\/journal.pone.0015846","volume":"6","author":"SF Rymo","year":"2011","unstructured":"Rymo SF, Gerhardt H, Sand FW, Lang R, Uv A, Betsholtz C (2011) A two-way communication between microglial cells and angiogenic sprouts regulates angiogenesis in aortic ring cultures. PLoS ONE 6(1):e15846. https:\/\/doi.org\/10.1371\/journal.pone.0015846","journal-title":"PLoS ONE"},{"issue":"8","key":"8_CR78","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00259-017-3677-5","volume":"44","author":"L Bekaert","year":"2017","unstructured":"Bekaert L, Valable S, Lechapt-Zalcman E et al (2017) [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis. Eur J Nucl Med Mol Imaging 44(8):1383\u20131392. https:\/\/doi.org\/10.1007\/s00259-017-3677-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"8_CR79","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/labinvest.3700482","volume":"86","author":"D Zagzag","year":"2006","unstructured":"Zagzag D, Lukyanov Y, Lan L et al (2006) Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Investig 86(12):1221\u20131232. https:\/\/doi.org\/10.1038\/labinvest.3700482","journal-title":"Lab Investig"},{"key":"8_CR80","doi-asserted-by":"publisher","unstructured":"Chia K, Mazzolini J, Mione M, Sieger D (2018) Tumor initiating cells induce cxcr4- mediated infiltration of pro-tumoral macrophages into the brain. elife 7. https:\/\/doi.org\/10.7554\/eLife.31918","DOI":"10.7554\/eLife.31918"},{"issue":"1","key":"8_CR81","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13046-016-0326-y","volume":"35","author":"L Mercurio","year":"2016","unstructured":"Mercurio L, Ajmone-Cat MA, Cecchetti S et al (2016) Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model. J Exp Clin Cancer Res 35(1):55. https:\/\/doi.org\/10.1186\/s13046-016-0326-y","journal-title":"J Exp Clin Cancer Res"},{"key":"8_CR82","doi-asserted-by":"publisher","unstructured":"Man J, Yu X, Huang H, et al (2018) Hypoxic induction of Vasorin regulates Notch1 turnover to maintain glioma stem-like cells. Cell Stem Cell 22(1):104\u2013118.e6. https:\/\/doi.org\/10.1016\/j.stem.2017.10.005","DOI":"10.1016\/j.stem.2017.10.005"},{"issue":"47","key":"8_CR83","doi-asserted-by":"publisher","first-page":"77457","DOI":"10.18632\/oncotarget.12681","volume":"7","author":"K Di","year":"2016","unstructured":"Di K, Lomeli N, Wood SD, Vanderwal CD, Bota DA (2016) Mitochondrial Lon is over-expressed in high-grade gliomas, and mediates hypoxic adaptation: potential role of Lon as a therapeutic target in glioma. Oncotarget 7(47):77457\u201377467. https:\/\/doi.org\/10.18632\/oncotarget.12681","journal-title":"Oncotarget"},{"key":"8_CR84","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.biomaterials.2017.01.001","volume":"121","author":"H Liu","year":"2017","unstructured":"Liu H, Xie Y, Zhang Y et al (2017) Development of a hypoxia-triggered and hypoxic radiosensitized liposome as a doxorubicin carrier to promote synergetic chemo\u2212\/radio-therapy for glioma. Biomaterials 121:130\u2013143. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.01.001","journal-title":"Biomaterials"},{"issue":"26","key":"8_CR85","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1056\/NEJMoa1610497","volume":"375","author":"CE Brown","year":"2016","unstructured":"Brown CE, Alizadeh D, Starr R et al (2016) Regression of glioblastoma after chimeric antigen receptor T-cell therapy. N Engl J Med 375(26):2561\u20132569. https:\/\/doi.org\/10.1056\/NEJMoa1610497","journal-title":"N Engl J Med"},{"key":"8_CR86","doi-asserted-by":"publisher","unstructured":"Reardon DA, Omuro A, Brandes AA, et al (2017) OS10.3 Randomized phase 3 study evaluating the efficacy and safety of Nivolumab vs Bevacizumab in patients with recurrent glioblastoma: checkmate 143. Neuro-Oncology 19(suppl_3): iii21\u2013iii21. https:\/\/doi.org\/10.1093\/neuonc\/nox036.071","DOI":"10.1093\/neuonc\/nox036.071"},{"issue":"10","key":"8_CR87","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S1470-2045(17)30517-X","volume":"18","author":"M Weller","year":"2017","unstructured":"Weller M, Butowski N, Tran DD et al (2017) Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. Lancet Oncol 18(10):1373\u20131385. https:\/\/doi.org\/10.1016\/S1470-2045(17)30517-X","journal-title":"Lancet Oncol"},{"issue":"3","key":"8_CR88","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11864-019-0619-4","volume":"20","author":"T McGranahan","year":"2019","unstructured":"McGranahan T, Therkelsen KE, Ahmad S, Nagpal S (2019) Current state of immunotherapy for treatment of glioblastoma. Curr Treat Options in Oncol 20(3):24. https:\/\/doi.org\/10.1007\/s11864-019-0619-4","journal-title":"Curr Treat Options in Oncol"},{"issue":"1","key":"8_CR89","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11060-019-03146-7","volume":"143","author":"CY Hui","year":"2019","unstructured":"Hui CY, Rudra S, Ma S, Campian JL, Huang J (2019) Impact of overall corticosteroid exposure during chemoradiotherapy on lymphopenia and survival of glioblastoma patients. J Neuro-Oncol 143(1):129\u2013136. https:\/\/doi.org\/10.1007\/s11060-019-03146-7","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"8_CR90","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.pjnns.2014.12.006","volume":"49","author":"P Zadora","year":"2015","unstructured":"Zadora P, Dabrowski W, Czarko K et al (2015) Preoperative neutrophil\u2013lymphocyte count ratio helps predict the grade of glial tumor \u2013 a pilot study. Neurol Neurochir Pol 49(1):41\u201344. https:\/\/doi.org\/10.1016\/j.pjnns.2014.12.006","journal-title":"Neurol Neurochir Pol"},{"issue":"4","key":"8_CR91","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00262-014-1651-7","volume":"64","author":"EJ Sayour","year":"2015","unstructured":"Sayour EJ, McLendon P, McLendon R et al (2015) Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma. Cancer Immunol Immunother 64(4):419\u2013427. https:\/\/doi.org\/10.1007\/s00262-014-1651-7","journal-title":"Cancer Immunol Immunother"},{"key":"8_CR92","doi-asserted-by":"publisher","unstructured":"Lowther DE, Goods BA, Lucca LE et al (2016) PD-1 marks dysfunctional regulatory T cells in malignant gliomas. JCI Insight 1(5). https:\/\/doi.org\/10.1172\/jci.insight.85935","DOI":"10.1172\/jci.insight.85935"},{"issue":"17","key":"8_CR93","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1158\/1078-0432.CCR-17-1846","volume":"24","author":"K Woroniecka","year":"2018","unstructured":"Woroniecka K, Chongsathidkiet P, Rhodin K et al (2018) T-cell exhaustion signatures vary with tumor type and are severe in glioblastoma. Clin Cancer Res 24(17):4175\u20134186. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1846","journal-title":"Clin Cancer Res"},{"issue":"1","key":"8_CR94","doi-asserted-by":"publisher","first-page":"e0169932","DOI":"10.1371\/journal.pone.0169932","volume":"12","author":"R Domenis","year":"2017","unstructured":"Domenis R, Cesselli D, Toffoletto B et al (2017) Systemic T cells immunosuppression of glioma stem cell-derived exosomes is mediated by monocytic myeloid-derived suppressor cells. PLOS ONE 12(1):e0169932. https:\/\/doi.org\/10.1371\/journal.pone.0169932","journal-title":"PLOS ONE"},{"issue":"19","key":"8_CR95","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1158\/0008-5472.CAN-16-0144","volume":"76","author":"AL Chang","year":"2016","unstructured":"Chang AL, Miska J, Wainwright DA et al (2016) CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells. Cancer Res 76(19):5671\u20135682. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0144","journal-title":"Cancer Res"},{"issue":"33","key":"8_CR96","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.18632\/oncotarget.26863","volume":"10","author":"CC Poon","year":"2019","unstructured":"Poon CC, Gordon PMK, Liu K et al (2019) Differential microglia and macrophage profiles in human IDH-mutant and -wild type glioblastoma. Oncotarget 10(33):3129\u20133143. https:\/\/doi.org\/10.18632\/oncotarget.26863","journal-title":"Oncotarget"},{"issue":"11","key":"8_CR97","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/neuonc\/nox054","volume":"19","author":"AS Berghoff","year":"2017","unstructured":"Berghoff AS, Kiesel B, Widhalm G et al (2017) Correlation of immune phenotype with IDH mutation in diffuse glioma. Neuro-Oncology 19(11):1460\u20131468. https:\/\/doi.org\/10.1093\/neuonc\/nox054","journal-title":"Neuro-Oncology"},{"issue":"6332","key":"8_CR98","doi-asserted-by":"publisher","first-page":"eaai8478","DOI":"10.1126\/science.aai8478","volume":"355","author":"AS Venteicher","year":"2017","unstructured":"Venteicher AS, Tirosh I, Hebert C et al (2017) Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science 355(6332):eaai8478. https:\/\/doi.org\/10.1126\/science.aai8478","journal-title":"Science"},{"issue":"1","key":"8_CR99","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40478-015-0266-3","volume":"3","author":"TA Jones","year":"2015","unstructured":"Jones TA, Jeyapalan JN, Forshew T et al (2015) Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-\u03baB pathways. Acta Neuropathol Commun 3(1):86. https:\/\/doi.org\/10.1186\/s40478-015-0266-3","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"8_CR100","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neo.2018.11.007","volume":"21","author":"R Chen","year":"2019","unstructured":"Chen R, Keoni C, Waker CA, Lober RM, Chen Y-H, Gutmann DH (2019) KIAA1549-BRAF expression establishes a permissive tumor microenvironment through NF\u03baB-mediated CCL2 production. Neoplasia 21(1):52\u201360. https:\/\/doi.org\/10.1016\/j.neo.2018.11.007","journal-title":"Neoplasia"},{"issue":"1","key":"8_CR101","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000481513","volume":"53","author":"AR Gilbert","year":"2018","unstructured":"Gilbert AR, Zaky W, Gokden M et al (2018) Extending the Neuroanatomic territory of diffuse midline glioma, K27M mutant: pineal region origin. Pediatr Neurosurg 53(1):59\u201363. https:\/\/doi.org\/10.1159\/000481513","journal-title":"Pediatr Neurosurg"},{"issue":"1","key":"8_CR102","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11060-018-2931-4","volume":"140","author":"RS D\u2019Amico","year":"2018","unstructured":"D\u2019Amico RS, Zanazzi G, Wu P, Canoll P, Bruce JN (2018) Pineal region glioblastomas display features of diffuse midline and non-midline gliomas. J Neuro-Oncol 140(1):63\u201373. https:\/\/doi.org\/10.1007\/s11060-018-2931-4","journal-title":"J Neuro-Oncol"},{"issue":"4","key":"8_CR103","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-018-1826-y","volume":"135","author":"DN Louis","year":"2018","unstructured":"Louis DN, Giannini C, Capper D et al (2018) cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma\/anaplastic astrocytoma, IDH-mutant. Acta Neuropathol 135(4):639\u2013642. https:\/\/doi.org\/10.1007\/s00401-018-1826-y","journal-title":"Acta Neuropathol"},{"issue":"1","key":"8_CR104","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40478-018-0553-x","volume":"6","author":"GL Lin","year":"2018","unstructured":"Lin GL, Nagaraja S, Filbin MG, Suv\u00e0 ML, Vogel H, Monje M (2018) Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma. Acta Neuropathol Commun 6(1):51. https:\/\/doi.org\/10.1186\/s40478-018-0553-x","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"8_CR105","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/neuonc\/noy145","volume":"21","author":"NAP Lieberman","year":"2019","unstructured":"Lieberman NAP, DeGolier K, Kovar HM et al (2019) Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy. Neuro-Oncology 21(1):83\u201394. https:\/\/doi.org\/10.1093\/neuonc\/noy145","journal-title":"Neuro-Oncology"},{"issue":"7717","key":"8_CR106","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41586-018-0389-3","volume":"560","author":"JH Lee","year":"2018","unstructured":"Lee JH, Lee JE, Kahng JY et al (2018) Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature 560(7717):243\u2013247. https:\/\/doi.org\/10.1038\/s41586-018-0389-3","journal-title":"Nature"},{"key":"8_CR107","doi-asserted-by":"publisher","unstructured":"Denicola\u00ef E, Tabouret E, Colin C et al (2016) Molecular heterogeneity of glioblastomas: does location matter? Oncotarget 7(1). https:\/\/doi.org\/10.18632\/oncotarget.6433","DOI":"10.18632\/oncotarget.6433"},{"issue":"3","key":"8_CR108","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00285-014-0822-7","volume":"71","author":"C Engwer","year":"2015","unstructured":"Engwer C, Hillen T, Knappitsch M, Surulescu C (2015) Glioma follow white matter tracts: a multiscale DTI-based model. J Math Biol 71(3):551\u2013582. https:\/\/doi.org\/10.1007\/s00285-014-0822-7","journal-title":"J Math Biol"},{"issue":"1","key":"8_CR109","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41593-018-0285-z","volume":"22","author":"J Wang","year":"2019","unstructured":"Wang J, Xu S-L, Duan J-J et al (2019) Invasion of white matter tracts by glioma stem cells is regulated by a NOTCH1\u2013SOX2 positive-feedback loop. Nat Neurosci 22(1):91\u2013105. https:\/\/doi.org\/10.1038\/s41593-018-0285-z","journal-title":"Nat Neurosci"},{"key":"8_CR110","doi-asserted-by":"publisher","unstructured":"Stowe HB, Miller CR, Wu J, Randazzo DM, Ju AW (2017) Pineal region glioblastoma, a case report and literature review. Front Oncol 7. https:\/\/doi.org\/10.3389\/fonc.2017.00123","DOI":"10.3389\/fonc.2017.00123"},{"issue":"1","key":"8_CR111","doi-asserted-by":"publisher","first-page":"C25","DOI":"10.1152\/ajpcell.00084.2014","volume":"307","author":"A Birbrair","year":"2014","unstructured":"Birbrair A, Zhang T, Wang Z-M et al (2014) Type-2 pericytes participate in normal and tumoral angiogenesis. Am J Physiol Cell Physiol 307(1):C25\u2013C38. https:\/\/doi.org\/10.1152\/ajpcell.00084.2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"8_CR112","doi-asserted-by":"publisher","unstructured":"Prazeres PHDM, Leonel C, Silva WN, et al (2020) Ablation of sensory nerves favours melanoma progression. J Cell Mol Med. Published online 20 July 2020. https:\/\/doi.org\/10.1111\/jcmm.15381","DOI":"10.1111\/jcmm.15381"}],"container-title":["Advances in Experimental Medicine and Biology","Tumor Microenvironments in Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-59038-3_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T15:11:20Z","timestamp":1624979480000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-59038-3_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030590376","9783030590383"],"references-count":112,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-59038-3_8","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"30 June 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}